Is a complete NSE/VILINBIO research report available?

No complete published report is available for nse/VILINBIO (NSE/VILINBIO) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

nse/VILINBIO stock profile: metrics, valuation and analysis

Market cap	823.1M
Revenue (ttm)	422.6M
Net income (ttm)	19.3M
EPS (ttm)	₹1.37
Shares out	14M
P/E (trailing)	43.1x
Volume	36,000
Beta	0.68

All NSE/VILINBIO indicators

Market & fundamental data

Available fields

191

Groups with data

Currency

INR

Showing 191 of 191 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	India
Country code	IN
Enterprise value	INR 810.4M
Exchange	National Stock Exchange of India
Financial currency	INR
First seen	2026-05-10
Industry	Medical - Pharmaceuticals
Industry PE	28.61
Isin	INE0L4V01013
Last refreshed	2026-09-12
Market cap	INR 823.1M
Price	INR 59
Price currency	INR
Sector	Healthcare
Sector PE	47.89
Sector PE Fwd	38.25
Sic	2834
Symbol	nse/VILINBIO
Website	https://www.vilinbiomed.co.in

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	2.34%
EV Earnings	42.02x
EV/EBIT	27.86x
EV/EBITDA	25.38x
EV/FCF	202x
EV/Sales	1.92x
FCF yield	0.49%
P/B ratio	2.9x
P/E ratio	43.07x
P/S ratio	1.95x
PE Ratio3 Y	84.13x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	6.88%
EBITDA Margin	7.56%
FCF margin	0.95%
Gross margin	10.97%
Gross Profit	INR 46.4M
Gross Profit Growth	251.09%
Gross Profit Growth Q	913.07%
Gross Profit Growth3 Y	-2.97%
Net Income	INR 19.3M
Net Income Growth	763%
Net Income Growth Q	1,693.24%
Net Income Growth Qo Q	1,071.46%
Net Income Growth3 Y	15.71%
Pretax Margin	6.72%
Profit Margin	4.56%
ROA	5.8
Roa5y	4.23
ROCE	10.2
ROE	7.5
Roe5y	4.74
ROIC	7.28
Roic5y	5.47

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	151.76%
Cagr3y	35.33%
EPS Growth	756.3
EPS Growth Q	1,662.5
EPS Growth Qo Q	1,024.5
EPS Growth3 Y	3.1
FCF Growth Qo Q	194.11%
OCF Growth	220.92%
OCF Growth Qo Q	-20.43%
Revenue Growth	185.37x
Revenue Growth Q	222.75x
Revenue Growth Qo Q	237.32x
Revenue Growth3 Y	50.75x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	INR 1.35
Assets	INR 349.4M
Cash	INR 14.7M
Current Assets	INR 273.8M
Current Liabilities	INR 64.4M
Debt	INR 2.1M
Debt EBITDA	INR 0.06
Debt Equity	INR 0.01
Debt FCF	INR 0.51
Equity	INR 283.7M
Interest Coverage	42.27
Liabilities	INR 65.7M
Long Term Assets	INR 75.6M
Long Term Liabilities	INR 1.3M
Net Cash	INR 12.6M
Net Cash By Market Cap	INR 1.54
Net Debt EBITDA	INR -0.4
Net Debt Equity	INR -0.04
Net Debt FCF	INR -3.15
Tangible Book Value	INR 283.7M
Tangible Book Value Per Share	INR 19.75
WACC	8.04

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	4.25
Inventory Turnover	6.47
Net Working Capital	INR 196.8M
Quick ratio	2.71
Working Capital	INR 209.4M
Working Capital Turnover	INR 2.92

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-0.92%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	151.6%
200-day SMA	35.21
3Y total return	147.9%
50-day SMA	45.79
50-day SMA vs 200-day SMA	50over200
All Time High	60.95
All Time High Change	-3.2%
All Time High Date	2026-09-09
All Time Low	15.4
All Time Low Change	283.12%
All Time Low Date	2024-08-09
ATR	2.34
Beta	0.68
Beta1y	0.51
Beta2y	0.4
Ch YTD	181.6
High	60.3
High52	60.95
High52 Date	2026-09-09
High52ch	-3.2%
Low	58.05
Low52	18.95
Low52 Date	2025-12-16
Low52ch	211.35%
Ma50ch	28.84%
Price vs 200-day SMA	67.59%
RSI	72.76
RSI Monthly	74.87
RSI Weekly	73.51
Sharpe ratio	1.61x
Sortino ratio	2.58
Total Return	-0.92%
Tr YTD	181.6
Tr1m	40.81%
Tr1w	8.76%
Tr3m	22.92%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	5,559,360%
Net Borrowing	-23,674,000
Shares Insiders	60.15%
Shares Out	13,950,000
Shares Qo Q	4.18%
Shares Yo Y	0.92%

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Average Volume	36,000x
Bv Per Share	19.75
CAPEX	INR -3M
Ch1m	40.81
Ch1w	8.76
Ch1y	151.6
Ch3m	22.92
Ch3y	147.9
Ch6m	70.27
Change	0.08%
Change From Open	0
Close	58.95
Days Gap	0.08
Depreciation Amortization	2,848,000
Dollar Volume	2,124,000
Earnings Date	2026-10-30
EBIT	INR 29.1M
EBITDA	INR 31.9M
EPS	INR 1.37
F Score	6
FCF	INR 4M
FCF EV Yield	0.5x
FCF Per Share	INR 0.29
Financing CF	10,126,000
Fiscal Year End	March
Founded	2,005
Graham Number	24.6729
Graham Upside	-58.18
Income Tax	INR 9.1M
Investing CF	-2,968,000
Is Primary Listing	1
Last Earnings Date	2026-05-30
Last Report Date	2026-03-31
Lynch Fair Value	INR 21.52
Lynch Upside	-63.52
Ma150	38.8
Ma150ch	52.06%
Ma20	48.29
Ma20ch	22.17%
Net CF	14,138,000
Next Earnings Date	2026-10-30
Open	59
P FCF Ratio	205.1
P OCF Ratio	117.9
Position In Range	42.22
Ppne	28,651,000
Price Date	2026-09-11
Price EBITDA	INR 25.78
Ptbv Ratio	2.9
Relative Volume	1.03x
Revenue	422,629,000x
Tax By Revenue	2.16x
Tax Rate	32.11%
Tr6m	70.27%
Volume	36,000

NSE/VILINBIO (NSE/VILINBIO)

Price

Financial snapshot

Fair-value bridge

Latest news · NSE/VILINBIO

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All NSE/VILINBIO indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Other indicators

Deeper analysis on NSE/VILINBIO

Frequently asked questions